(S (NP (NP (NNP Predicting) (NML (NN drug) (HYPH -) (NN target)) (NNS interactions)) (-LRB- -LRB-) (NP (NN DTI)) (-RRB- -RRB-)) (VP (VBZ is) (NP (NP (DT an) (JJ essential) (NN part)) (PP (IN of) (NP (NP (DT the) (NML (NN drug) (NN discovery)) (NN process)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT an) (JJ expensive) (NN process)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NN time) (CC and) (NN cost))))))))))))) (. .))
(S (ADVP (RB Therefore)) (, ,) (S (VP (VBG reducing) (NP (NN DTI) (NN cost)))) (VP (MD could) (VP (VB lead) (PP (IN to) (NP (NP (VBN reduced) (NN healthcare) (NNS costs)) (PP (IN for) (NP (DT a) (NN patient))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (DT a) (RB precisely)) (VP (VBN learned) (NP (NN molecule) (NN representation)) (PP (IN in) (NP (DT a) (NN DTI) (NN model))))) (VP (MD could) (VP (VB contribute) (PP (IN to) (NP (NP (VBG developing) (JJ personalized) (NN medicine)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD will) (VP (VB help) (NP (JJ many) (JJ patient) (NNS cohorts)))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (S (NP (PRP we)) (VP (VBP propose) (NP (DT a) (JJ new) (NN molecule) (NN representation)) (PP (VBN based) (PP (IN on) (NP (DT the) (ADJP (NN self) (HYPH -) (NN attention)) (NN mechanism)))))) (, ,) (CC and) (S (NP (DT a) (JJ new) (NNP DTI) (NN model)) (VP (VBG using) (NP (PRP$ our) (NN molecule) (NN representation)))) (. .))
(S (NP (DT The) (NNS experiments)) (VP (VBP show) (SBAR (IN that) (S (NP (PRP$ our) (NN DTI) (NN model)) (VP (VBZ outperforms) (NP (NP (DT the) (NN state)) (PP (IN of) (NP (DT the) (NN art)))) (PP (IN by) (NP (ADVP (RB up) (PP (IN to) (NP (NML (CD 4.9) (NN %)) (NNS points)) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (NN area)) (PP (IN under) (NP (DT the) (NN precision) (HYPH -) (NN recall))))))))) (NN curve))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP (NP (DT a) (NN study)) (VP (VBG using) (NP (DT the) (NNP DrugBank) (NN database)))) (VP (VBZ proves) (SBAR (IN that) (S (NP (PRP$ our) (NN model)) (ADVP (RB effectively)) (VP (VBZ lists) (NP (NP (DT all) (VBN known) (NNS drugs)) (VP (VBG targeting) (NP (NP (DT a) (JJ specific) (NN cancer) (NN biomarker)) (PP (IN in) (NP (DT the) (NML (JJ top) (HYPH -) (CD 30)) (NN candidate) (NN list)))))))))) (. .))
